Talam Biotech company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Bridge | Alive

Total Raised


Mosaic Score

+10 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Talam Biotech

Talam Biotech is a biotech firm that aims to feed the world with safe foods produced sustainably. MicroGen uses nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil. It serves companies operating in the agriculture sector. Talam Biotech was formerly known as MicroGen Biotech. The company was founded in 2012 and is based in Dublin, Ireland.

Talam Biotech Headquarter Location

NovaUCD Belfield Innovation Park

Dublin 4,


+353 0599175236

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Talam Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Talam Biotech is included in 2 Expert Collections, including Omics.



275 items


Advanced Materials

1,256 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

Talam Biotech Patents

Talam Biotech has filed 1 patent.

The 3 most popular patent topics include:

  • Bacteriology
  • Land management
  • Microbiology
patents chart

Application Date

Grant Date


Related Topics



Microbiology, Sustainable agriculture, Microbiomes, Land management, Bacteriology


Application Date


Grant Date


Related Topics

Microbiology, Sustainable agriculture, Microbiomes, Land management, Bacteriology



Latest Talam Biotech News

Talam Biotech Announces Bridge Round Closing, Leadership Team Named

Jun 11, 2022

Talam Biotech Announces Bridge Round Closing, Leadership Team Named Talam Biotech (formerly MicroGen Biotech), which uses microbes found in the soil to develop solutions that help agriculture protect the integrity of our food and create a more sustainable planet, today announced it has closed a successful bridge round of funding. Existing investors Fulcrum Global Capital and The Yield Lab Europe co-lead the investment for the company, which also announced its robust leadership team of industry veterans. Advertisement The new team is led by Chief Executive Officer John Chrosniak, formerly the CEO of Invaio Sciences and chief strategy officer of Corteva. He brings to the role his extensive leadership and experience with agriculture inputs and sustainability. “Agriculture desperately needs more innovation, especially when it comes to the promise of natural technologies. Talam delivers on that promise,” says Chrosniak. “Our proprietary technology is a powerful platform that harnesses the soil and its natural microbiome to solve major challenges facing our agriculture and food systems. We chose to focus our efforts initially on the problem of soil contaminants, especially heavy metals, negatively impacting the quality of major food crops.” Joining Chrosniak on the leadership team is: Chief Financial Officer Eoin Grindley brings deep commercial finance and fundraising experience in large-scale and fast-growing entrepreneurial organizations. Head of Research & Development Dr. Thomas Malvar has extensive experience developing agricultural biotech products with Monsanto company. Most recently he was R&D lead for Invaio Sciences. Co-founder and Scientific Advisor Dr. David Ryan has worked in environmental biotechnology for more than 20 years with a focus on soil bioremediation and microbial metal resistance systems. Co-founder and Scientific Advisor Dr. David Dowling is a world leading scientist in environmental and agricultural biotech research with more than 30 years of experience in phytoremediation, plant growth promotion and soil microbiology. “We’re excited to see this highly experienced executive team leading Talam into the next phase of the company’s growth,” says Duane Cantrell, Co-founder of Fulcrum Global Capital and Talam Biotech chairman of the board. “They are developing critical innovations that will help make our food safer, mitigate soil contaminants and increase yields.” Cantrell is joined on the board by: John Carrigan, Investment Director, Yield Lab Europe William Buckner, Former CEO of Noble Research Institute and CEO of Bayer Crop Science North America Dr. Roger Beachy, Former Director of NIFA and National Academy of Science Member John Chrosniak, Chief Executive Officer of Talam Biotech Dr. David Ryan, Co-Founder and Scientific Advisor With this exceptional leadership team and advisors, Talam is looking forward to advancing its innovative solutions for the benefit of farmers and consumers to address these critical needs. Talam sees significant opportunities to collaborate and develop new partnerships in its mission to help protect the integrity of our food and create a more sustainable planet. 015Talam Biotech Announces Bridge Round Closing, Leadership Team Named Subscribe Today For Subscribe PR Newswire is a distributor of press releases headquartered in New York City. The service was created in 1954 to allow companies to electronically send press releases to news organizations. See all author stories here. Leave a Reply

Talam Biotech Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Talam Biotech Rank

  • When was Talam Biotech founded?

    Talam Biotech was founded in 2012.

  • Where is Talam Biotech's headquarters?

    Talam Biotech's headquarters is located at NovaUCD, Dublin 4.

  • What is Talam Biotech's latest funding round?

    Talam Biotech's latest funding round is Bridge.

  • How much did Talam Biotech raise?

    Talam Biotech raised a total of $6M.

  • Who are the investors of Talam Biotech?

    Investors of Talam Biotech include Fulcrum Global Capital, The Yield Lab, Extreme Tech Challenge, SVG Ventures, Sirius Venture Capital and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.